Home > Insider Trading > Filing (0001181431-10-041760)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1375200	Nupathe Inc.	PATH	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1318119	Birchmere Ventures Iii Tsib Lp	2835 East Carson Street Suite 208 Pittsburgh PA 15203	No	No	No	Yes
1498235	Bv3 Llc	2835 East Carson Street Suite 208 Pittsburgh PA 15203	No	No	No	Yes
1498240	Bv3 Management Lp	2835 East Carson Street Suite 208 Pittsburgh PA 15203	No	No	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-08-11	206,004	$0.00	206,004	No	4	C	Indirect	By Birchmere Ventures III TSIB LP
Common Stock	Acquisiton	2010-08-11	157,309	$0.00	363,313	No	4	C	Indirect	By Birchmere Ventures III TSIB LP
Common Stock	Acquisiton	2010-08-11	64,529	$8.00	427,842	No	4	C	Indirect	By Birchmere Ventures III TSIB LP
Common Stock	Acquisiton	2010-08-11	27,066	$10.00	454,908	No	4	P	Indirect	By Birchmere Ventures III TSIB LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Birchmere Ventures III TSIB LP
No	4	C	Indirect	By Birchmere Ventures III TSIB LP
No	4	C	Indirect	By Birchmere Ventures III TSIB LP
No	4	P	Indirect	By Birchmere Ventures III TSIB LP

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2010-08-11	1,290,323	$0.00	206,004	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2010-08-11	1,096,775	$0.00	157,309	$0.00
Series B Convertible Preferred Stock	Warrant to Purchase Series B Convertible Preferred Stock	Disposition	2010-08-11	19,549	$0.00	19,549	$0.93
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2010-08-11	2,439	$0.00	2,439	$7.45
Common Stock	Convertible Promissory Note	Disposition	2010-08-11	0	$0.00	64,529	$8.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect
0	2009-08-20	2016-08-20	No	4	C	Indirect
2,439	2009-08-20	2016-08-20	No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

In connection with the Issuer's initial public offering (the "IPO"), the Series A Convertible Preferred Stock, including all accrued and unpaid dividends as of the date of conversion, converted into Issuer Common Stock on a 1-for-8.0149 basis and had no expiration date.
These securities are owned directly by Birchmere Ventures III TSIB LP. BV3 LLC is the general partner of BV3 Management LP, which is the general partner of Birchmere Ventures III TSIB LP. BV3 LLC and BV3 Management LP disclaim benefical ownership in these securities to the extent it exceeds their pecuniary interest therein.
In connection with the Issuer's IPO, the Series B Convertible Preferred Stock, including all accrued and unpaid dividends as of the date of conversion, converted into Issuer Common Stock on a 1-for-8.0149 basis and had no expiration date.
In connection with the Issuer's IPO, the Warrant to Purchase 19,549 shares of Series B Convertible Preferred Stock at $0.93 per share converted into a Warrant to Purchase 2,439 shares of the Issuer's Common Stock at $7.45 per share, as a result of the 1-for-8.0149 reverse stock split.
In connection with the Issuer's IPO, the Convertible Promissory Note, including $13,596.61 in accrued and unpaid interest as of the date of conversion, converted into 64,529 shares of the Issuer's Common Stock at $8 per share.